Kintor Pharmaceutical Limited
KNTPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $503,003 | $524,084 | $3,220,591 | $24,902 |
| - Cash | $147,419 | $445,499 | $865 | $930 |
| + Debt | $133,009 | $253,920 | $286,386 | $159,733 |
| Enterprise Value | $488,593 | $332,505 | $3,506,112 | $183,705 |
| Revenue | $5,000 | $0 | $0 | $34,231 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$4,730 | -$42,229 | -$2,737 | $34,231 |
| % Margin | -94.6% | – | – | 100% |
| EBITDA | -$128,370 | -$1,055,821 | -$956,446 | -$827,967 |
| % Margin | -2,567.4% | – | – | -2,418.8% |
| Net Income | -$155,292 | -$1,060,820 | -$954,369 | -$842,095 |
| % Margin | -3,105.8% | – | – | -2,460% |
| EPS Diluted | -0.36 | -2.47 | -2.53 | -2.36 |
| % Growth | 85.4% | 2.4% | -7.2% | – |
| Operating Cash Flow | -$199,080 | -$387,581 | -$961 | -$1,051 |
| Capital Expenditures | -$1,680 | -$2,723 | -$27 | -$76 |
| Free Cash Flow | -$200,760 | -$390,304 | -$989 | -$1,128 |